Meeting Planned By FDA On Collecting Subgroup Data For Product Submissions
This article was originally published in The Gray Sheet
Executive Summary
The agency plans a public meeting, required by the FDA Safety and Innovation Act, to chart progress on its action plan to improve industry data collection on demographic subgroups for product submissions and labeling for Feb. 29 at its Maryland headquarters.